Inhibition of SLITRK4 significantly suppresses CRC liver metastasis by modulating cell‐matrix adhesion, reducing angiogenesis and tumor‐associated macrophage infiltration in the tumor microenvironment. Here, SLITRK4 is linked to neoplasm.